HOME >> BIOLOGY >> NEWS
Study in Royal Society journal on possible genetic factors in social responsiblity

Proceedings of The Royal Society B: Biological Sciences

Geographic potential of Argentine ants (Linepithema humile Mayr) in the face of global climate change by Dr N Roura-Pascual, Dr AV Suarez, Dr C Gmez, Dr P Pons, Dr Y Touyama, Dr AL Wild and Dr AT Peterson

We examined the potential worldwide distribution of the Argentine ant (Linepithema humile) based on current climate models and also in the face of projected future climate change. Native to South America, Argentine ants have invaded broad areas around the world. Our results suggest that Argentine ants still have the potential to spread into areas not currently known to be occupied, particularly in regions of Africa and Asia. Higher latitudes appear to become more suitable for the Argentine ant under global climate change scenarios. Because invasion processes have the potential to alter global biodiversity considerably, this improved knowledge of the potential geography of the Argentine ant should be considered in preventive efforts.
Contact: Dr Nria Roura-Pascual, Departament de Cincies Ambientals, Universitat de Girona, Facultat de Cincies, GIRONA, 17071, Spain

Genetic and environmental contributions to pro-social attitudes: a twin study of social responsibility by Dr JP Rushton

A new study surprisingly shows genes, more than home environment, shape social responsibility attitudes. 174 pairs of identical twins and 148 pairs of non-identical twins from the University of London Twin Register rated themselves on 22 social attitudes such as "I am a person people can count on" and "It is important to finish anything you have started." Identical twins were almost twice as similar as non-identical twins. Genes determined 42%; home environment, 23%; and the non-home environment, the remainder of the variance. The ratings predict real life behaviour such as voting and helping others, implying these too have a genetic component.
Contact: Dr John Ru
'"/>

Contact: Tim Watson
tim.watson@royalsoc.ac.uk
44-207-451-2508
Royal Society
29-Nov-2004


Page: 1 2 3 4 5 6 7

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:
(Date:4/1/2015)... 2015   Medisafe ™, the leading global medication ... iOS and Android smartphones and tablets, ... the platform to allow patients to track and correlate ... time, patients will be able to visualize in real-time ... biometrics, such as glucose levels and blood pressure. ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... and Voice Biometrics - Global Strategic Business Report" report to ... Face and Voice Biometrics in US$ Thousands by the following Segments: ... for the US, Canada , Japan ... , Middle East & Africa ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
(Date:4/16/2015)... (PRWEB) April 16, 2015 Capillus, ... distribution and physician network in Europe and Asia. ... has appointed Fernando Bermúdez, former Business Development Director ... An industry veteran, Mr. Bermúdez’s professional achievements include ... in Spain, while also penetrating the Portuguese marketplace ...
(Date:4/16/2015)... OncoTAb, Inc., a ... spin-out company, announced today the appointment of physician ... Chief Operating Officer (COO). Cooper brings to OncoTAb ... clinical diagnostic and biotechnology platforms in the fields ... extensive career transcends the field of medical and ...
(Date:4/16/2015)... 2015 /CNW/ - Bioenterprise Corporation is pleased to announce that ... Charlottetown , PEI.  Bioenterprise has established a ... Council for the commercialization of agricultural technologies and innovations. ... PEI ADAPT.  They have been at the heart of ... explains Dave Smardon , President & CEO of ...
(Date:4/16/2015)... -- Avelas Biosciences, an in vivo cancer ... that it has initiated a Phase 1b study of ... primary, non-recurrent breast cancer undergoing surgery. In commencing the ... Steven Chen , M.D., as vice president of ... study will enroll up to 39 women with stage ...
Breaking Biology Technology:Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2OncoTAb Names Dr. David L. Cooper as COO 2Bioenterprise Corporation Expands into the Maritimes 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3
Cached News: